Cold Sore Treatment Clinical Trials

Intertek provides herpes simplex virus patient recruitment solutions and experienced investigators for clinical trials.

Intertek has considerable experience with the recruitment and management of clinical trials to determine the efficacy and safety of novel treatments for cold sores. Clinical trial expertise includes a database of pre-qualified volunteers, and examiners with experience of the assessment of symptoms and healing time in relation to cold sores. Through a number of research partners, Intertek are also able to provide supporting virology services, to complement our clinical research. 

Cold sore clinical trials background

Cold sores are caused by the herpes simplex virus (HSV), primarily a HSV type 1 infection of the lips and perioral skin known as Herpes simplex labialis (HSL).

Several factors can trigger an episode of cold sores, including emotional stress, tiredness or feeling run down, menstruation, strong sunlight exposure on the lips, an injury to the mouth or a dental procedure, and fever. For many people, however, the trigger is unknown. HSL is prevalent, occurring in approximately 20% of people in the UK and up to 40% of adults worldwide. Cold sores usually resolve on their own without treatment in 7-10 days, but antiviral treatments may be used to help reduce the duration and severity of symptoms. 

Contact us to see how Intertek can help your organization with Cold Sore Treatment Clinical Trials.